| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | JAGX | Common Stock | Options Exercise | +1.15K | +711.18% | 1.31K | May 17, 2023 | Direct | F2, F3 | ||
| holding | JAGX | Common Stock | 59 | May 17, 2023 | See Footnote | F3, F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | JAGX | Restricted stock units | Options Exercise | $0 | -1.15K | -100% | $0.00* | 0 | May 17, 2023 | Common Stock | 1.15K | Direct | F1, F2, F3, F4 |
| Id | Content |
|---|---|
| F1 | Granted pursuant to the issuer's 2014 Stock Incentive Plan. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. |
| F3 | On January 23, 2023, the issuer effected a 75-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "January 2023 Reverse Stock Split). Upon effectiveness of the January 2023 Reverse Stock Split, every 75 shares of voting common stock was automatically converted into one share of voting common stock. |
| F4 | The restricted stock units were previously reported as covering 85,900 shares, but were adjusted to reflect the January 2023 Reverse Stock Split. Such restricted stock units were granted on March 28, 2022 and vested in full on May 17, 2023. Vested shares will be delivered to the reporting person on the vesting date provided in the grant notice. |
| F5 | Securities held directly by JBS Healthcare Ventures LLC. Mr. Siegel, by virtue of his position as the sole member of JBS Healthcare Ventures LLC, may be deemed to beneficially own the securities held by JBS Healthcare Ventures LLC for purposes of Section 16. |